Skip to main
CMPI
CMPI logo

Checkmate Pharmaceuticals (CMPI)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Checkmate Pharmaceuticals (CMPI) Stock

About Checkmate Pharmaceuticals (CMPI)

Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in com...read more
Market cap$231.4M
Today's volume
Revenue (TTM)
Avg. daily volume213.6K
EBITDA (TTM)
Open
Price / earnings ratio-3.60x
Today's range
Debt / equity
52 week range$2 - $10.5
5 year debt / equity
Beta (LTM)1.03x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsMay 12, 2022
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jun 19, 2025, the market cap for CMPI stock is $231.41M

The current P/E ratio for CMPI stock is -3.6

The 52-week high for CMPI stock is $10.50. The current CMPI stock price $undefined is 100.00% below its 52-week high

The 52-week low for CMPI stock is $2. The current CMPI stock price $undefined has increased 100.00% from its 52-week low

No, the CMPI stock does not pay dividends to its shareholders

How to buy CMPI stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CMPI stock

    Navigate to the Explore page. Then, type CMPI into the search bar. When you see CMPI stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CMPI stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Checkmate Pharmaceuticals Stock Earnings

The value each CMPI share was expected to gain vs. the value that each CMPI share actually gained.

Checkmate Pharmaceuticals (CMPI) reported Q4 2021 earnings per share (EPS) of -$0.62, beating estimates of -$0.74 by 16.22%. In the same quarter last year, Checkmate Pharmaceuticals's earnings per share (EPS) was $1.30. Checkmate Pharmaceuticals is expected to release next earnings on 05/12/2022, with an earnings per share (EPS) estimate of $0.

Buy Checkmate Pharmaceuticals (CMPI) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.